METHODS	We performed a randomized , open-label , multicenter , superiority study of 379 nucleos ( t ) ide-nave patients with hepatitis B e antigen ( HBeAg ) - positive ( n = 264 ) or HBeAg-negative ( n = 115 ) CHB .\